Exvade Biosciences


Launched:

2022

Management:

Nassir Mokarram-Dorri

Duke Inventor(s):

Ravi Bellamkonda, Tarun Saxena, Nassir Mokarram-Dorri

 

 

 

Exvade Bioscience is engaged in developing groundbreaking technologies to better monitor and treat malignant brain tumors. Their platform technology has received the Breakthrough Designation from the U.S. Food and Drug Administration (FDA) and has been supported by several grants from the National Institute of Health (NIH).


Success Story